Active, Not Recruiting
A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Cancer
NCT06057610
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-PositiveRecurrent or Metastatic Breast Cancer, +4 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China